StockNews.com started coverage on shares of SigmaTron International (NASDAQ:SGMA – Free Report) in a research report released on Thursday. The firm issued a hold rating on the technology company’s stock.
SigmaTron International Stock Performance
Shares of SGMA opened at $2.67 on Thursday. The company has a current ratio of 1.15, a quick ratio of 0.36 and a debt-to-equity ratio of 0.09. The firm’s fifty day simple moving average is $2.83 and its two-hundred day simple moving average is $3.86. SigmaTron International has a 12 month low of $2.27 and a 12 month high of $6.47. The stock has a market capitalization of $16.34 million, a P/E ratio of -2.70 and a beta of 0.87.
SigmaTron International (NASDAQ:SGMA – Get Free Report) last announced its quarterly earnings data on Thursday, September 19th. The technology company reported ($0.54) earnings per share (EPS) for the quarter. SigmaTron International had a negative net margin of 1.67% and a negative return on equity of 9.05%. The business had revenue of $84.78 million during the quarter.
Institutional Trading of SigmaTron International
About SigmaTron International
SigmaTron International, Inc operates as an independent provider of electronic manufacturing services (EMS). Its EMS services include printed circuit board assemblies, electro-mechanical subassemblies, and completely assembled (box-build) electronic products. The company also offers automatic and manual assembly and testing of products; material sourcing and procurement services; manufacturing and test engineering support services; design services; warehousing and distribution services; compliance reporting, and assistance in obtaining product approval from governmental and other regulatory bodies.
Featured Articles
- Five stocks we like better than SigmaTron International
- Comparing and Trading High PE Ratio Stocks
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- How Investors Can Find the Best Cheap Dividend Stocks
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for SigmaTron International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SigmaTron International and related companies with MarketBeat.com's FREE daily email newsletter.